Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer carbonate (Novivel) in non-dialysis CKD patients with hyperphosphatemia
CTR20170139Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of sevelamer carbonate in hyperphosphatemia, chronic kidney disease (CKD), sponsored by Sanofi. Started Apr 2017; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20170139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170139.